Section 67A Defence to offence of contravening section 63(a) or (b): product not sold or suppliedF1
This section applies in a case where—
a person (“the defendant”) is charged with an offence under section 67(2) of contravening section 63(a) or (b) in respect of a medicinal product; and
the product is not sold or supplied in its adulterated state.
Where the defendant is charged with contravening section 63(a), it is a defence for the defendant to prove that—
the adulteration took place—
at a registered pharmacy, or
in the course of the provision of a relevant pharmacy service;
the defendant—
was a registrant acting in the course of his or her profession, or
was acting under the supervision of a person who was a registrant acting in the course of his or her profession; and
at the time of the alleged contravention, the defendant did not know that the product was being adulterated.
Where the defendant is charged with contravening section 63(b), it is a defence for the defendant to prove that—
the adulteration took place—
at a registered pharmacy, or
in the course of the provision of a relevant pharmacy service;
the person who adulterated the product—
was a registrant acting in the course of his or her profession, or
was acting under the supervision of a person who was a registrant acting in the course of his or her profession; and
at the time of the alleged contravention, the defendant did not know that the product had been adulterated.
Annotations
Textual amendments
- F1
Ss. 67A-67E inserted (16.4.2018) by The Pharmacy (Preparation and Dispensing Errors Registered Pharmacies) Order 2018 (S.I. 2018/181), arts. 1(3), 4 (with art. 2); S.I. 2018/402, art. 2
- F2
S. 67A(2)(a) substituted (1.12.2022) by The Pharmacy (Preparation and Dispensing Errors – Hospital and Other Pharmacy Services) Order 2022 (S.I. 2022/851), arts. 1(3), 5(2) (with art. 3); S.I. 2022/1024, art. 2
- F3
S. 67A(3)(a) substituted (1.12.2022) by The Pharmacy (Preparation and Dispensing Errors – Hospital and Other Pharmacy Services) Order 2022 (S.I. 2022/851), arts. 1(3), 5(3) (with art. 3); S.I. 2022/1024, art. 2
Notes on Part III
Modifications
- C1
Part III (ss.51-68) modified (1.1.1995) by S.I. 1994/3144, reg. 9(9)
- C2
Pt. III amendment to earlier affecting provision SI 1994/3144 reg. 9 (30.10.2005) by Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005 (S.I. 2005/2759), regs. 1(a), 2(12)